In the JAMA review of shoulder pain, what is the recommended first-line treatment for most shoulder diagnoses? Test your knowledge in this week's RheumIQ at https://t.co/TBlB4pmnKa https://t.co/mKClL2P0Tc

Retrospective Medicare comparison 450 paired #PMR cohorts Rx w/ IL-6 inhib or csDMARDs. At 1 yr, IL-6i pts (vs csDMARD) had signif more GC D/C (adj HR 1.28) or minimal GC use (<3mg/d) (aHR 1.28). Hosp. infxn 2X higher in IL-6i (12.2 vs 5.7 per 100 PY) in year 1, but not year 2 https://t.co/G4eIusHDPa

True or False: Mycophenolate mofetil is teratogenic and should be avoided during pregnancy in patients with lupus nephritis. Test your knowledge in this week's RheumIQ at https://t.co/TBlB4pmnKa https://t.co/1AMl8LtNZy

True or False: Mycophenolate mofetil is teratogenic and should be avoided during pregnancy in patients with lupus nephritis. Test your knowledge in this week's RheumIQ at https://t.co/TBlB4pmnKa. https://t.co/Duci28drkL

Efgartigimod Efficacy in Idiopathic Inflammatory Myopathy Today Argenx announced the results of their Phase 3 "ALKIVIA" study; demonstrating efficacy and safety of subcutaneous efgartigimod for Idiopathic Inflammatory Myopathy (IIM, AKA inflammatory myositis). https://t.co/9tgAM8YVh1

SLE & Dermatomyositis rashes maybe classically red or violaceous in Whites,but different in people of color, where erythema often appears brown/violaceous, Gottron papules can be mistaken for "dry skin." This delays dx, especially in anti-MDA5+ RP-ILD, where rash may be the https://t.co/DIe2OJhZIc

In a claims analysis, 28.1% of patients with PsA had ≥1 predictor of IBD development at PsA diagnosis. 📊Which predictors had the highest association with future IBD? Click to learn more: https://t.co/9c81Z7YsbA Sponsored by AbbVie Medical Affairs + Health Impact. https://t.co/ytgcUfwyAZ

In rheumatoid arthritis, which RA-specific factor is the strongest modifiable driver of venous thromboembolism risk? Test your knowledge in this week's RheumIQ at https://t.co/TBlB4pmnKa. https://t.co/L69CPXWqfl

Misdiagnosis of Still's Disease High fever, strange rashes, scary labs often lead to a consideration of Still's disease (AOSD or systemic JIA). Yet the dramatic onset of a systemic disorder may overlap with another, and possibly as rare, systemic disorder that should not be https://t.co/mCbNBAt9T5

Tune in for an expert conversation on the latest data from SELECT-SWITCH, including discussion about the EULAR 2026 post hoc analysis of primary and secondary TNFi nonresponders. Sponsored by AbbVie Medical Affairs + Health Impact. https://t.co/Fkdgk1T7qm https://t.co/W1jrlU3R5b

Risk of Venous Thromboembolism in Rheumatoid Arthritis RA confers a 50–100% excess risk of venous thromboembolism (VTE) compared with the general population, with adjusted hazard/odds ratios ranging from 1.3–2.2 across large cohort studies (Vojinovic, Askling, Antovic; https://t.co/IsS6vqo6vU

Latest #s: EHR estimates from 6 large US medical systems, estimated prevalence of autoimmune Dz (AID) to be >15 million (4.6% US population); 34% have > 1 AID. Women have 2x risk. Sex ratio of 1.7:1 F:M. https://t.co/tfSCpRqHbY https://t.co/VckjIoGOaa

JAMA: Review of Shoulder Pain JAMA Internal Medicine (Haas et al, 2026) has published a clinical overview to the approach, diagnosis and management of Shoulder Pain. https://t.co/xYSahFksx9 https://t.co/kTIml2mD6k

Joint Pain Prevalence is not Declining A current report from the national NHIS survey shows that over half of US adults diagnosed with arthritis reported moderate to severe joint pain. https://t.co/zq7pGaZO72 https://t.co/kvco72v5IZ

MASLD - Spanish review of 330 pts (101 psoriasis, 127 PsA, 102 controls) found metabolic-dysfunc-assoc steatotic liver Dz in 48% PsO, 32% PsA, 9% controls (p < 0.001). FibroScan tended higher in PsO 6.01 PsA 5.1 vs 4.9 controls https://t.co/wPxbLwVlOW https://t.co/ZtqYX5HPZa